Zhao Guifen - Sinocelltech CFO Director
688520 Stock | 39.00 0.62 1.62% |
Director
Zhao Guifen is CFO Director of Sinocelltech Group
Age | 57 |
Address | No. 31 Kechuang 7th Street, Beijing, China, 100176 |
Phone | 86 10 5862 8288 |
Web | https://www.sinocelltech.com |
Sinocelltech Management Efficiency
The company has return on total asset (ROA) of 0.1022 % which means that it generated a profit of $0.1022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (38.6441) %, meaning that it generated substantial loss on money invested by shareholders. Sinocelltech's management efficiency ratios could be used to measure how well Sinocelltech manages its routine affairs as well as how well it operates its assets and liabilities. At present, Sinocelltech's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 197.5 M, whereas Total Assets are forecasted to decline to about 2.1 B.Similar Executives
Showing other executives | DIRECTOR Age | ||
Yonglin Li | China Petroleum Chemical | 57 | |
Wang Li | Kweichow Moutai Co | 51 | |
Tao Wan | China Petroleum Chemical | 56 | |
Jun Li | China Telecom Corp | 48 | |
Guangxiu Shan | China State Construction | 53 | |
Ke Tang | China Telecom Corp | 50 | |
Yiqun Ling | China Petroleum Chemical | 61 | |
Wensheng Huang | China Petroleum Chemical | 57 | |
Fuxiao Shen | PetroChina Co Ltd | 54 | |
Guiqing Liu | China Telecom Corp | 58 | |
Mingjun Xu | China Shenhua Energy | 61 | |
Pizheng Li | China Mobile Limited | 58 | |
Zhichun Zhang | Ping An Insurance | 48 | |
Hongbin Liu | China Petroleum Chemical | 61 | |
Fangzheng Jiao | PetroChina Co Ltd | 61 | |
Hui Liu | China Life Insurance | 54 | |
Peng Zhao | China Life Insurance | 51 | |
Ronghua Li | China Mobile Limited | 58 | |
Lixin Ren | PetroChina Co Ltd | 56 | |
Fangfang Cai | Ping An Insurance | 50 |
Management Performance
Return On Equity | -38.64 | ||||
Return On Asset | 0.1 |
Sinocelltech Group Leadership Team
Elected by the shareholders, the Sinocelltech's board of directors comprises two types of representatives: Sinocelltech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sinocelltech. The board's role is to monitor Sinocelltech's management team and ensure that shareholders' interests are well served. Sinocelltech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sinocelltech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fanbin Pan, Head Department | ||
Jie Ma, Financial Director | ||
Liangzhi Xie, Chairman GM | ||
Zhao Guifen, CFO Director | ||
Li Tang, Secretary GM | ||
Yang Wang, Deputy Director |
Sinocelltech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sinocelltech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -38.64 | ||||
Return On Asset | 0.1 | ||||
Profit Margin | (0.01) % | ||||
Operating Margin | 0.33 % | ||||
Current Valuation | 19.41 B | ||||
Shares Outstanding | 445.34 M | ||||
Shares Owned By Insiders | 77.23 % | ||||
Shares Owned By Institutions | 5.45 % | ||||
Price To Sales | 7.10 X | ||||
Revenue | 1.89 B |
Currently Active Assets on Macroaxis
Other Information on Investing in Sinocelltech Stock
Sinocelltech financial ratios help investors to determine whether Sinocelltech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinocelltech with respect to the benefits of owning Sinocelltech security.